MAPT and Alzheimer disease: Recently, an analysis of cerebrospinal fluid (CSF) from AD patients bearing the protective rs3764650 allele reported a decrease of CSF Aβ1-42 although total tau and phosphorylated tau levels remained unchanged [63].